Maamar, Adel https://orcid.org/0000-0001-8352-3613
Faleur, Claude
Pedrono, Kristell
Adeux, Marie-Pierre
Anne, Magali
Verdes, Adeline
Fillâtre, Pierre
Debarre, Matthieu
Mercier, Nathalie
Revest, Matthieu
Massart, Nicolas
Poilvet, Noémie
Terzi, Nicolas
Tadié, Jean-Marc
Gacouin, Arnaud
Laviolle, Bruno
Funding for this research was provided by:
Ministère des Affaires Sociales et de la Santé (PHRIP-18-0299, PHRIP-18-0299, PHRIP-18-0299, PHRIP-18-0299, PHRIP-18-0299, PHRIP-18-0299, PHRIP-18-0299, PHRIP-18-0299, PHRIP-18-0299, PHRIP-18-0299, PHRIP-18-0299, PHRIP-18-0299, PHRIP-18-0299, PHRIP-18-0299, PHRIP-18-0299, PHRIP-18-0299)
Article History
Received: 9 April 2025
Accepted: 9 July 2025
First Online: 18 July 2025
Declarations
:
: The trial was approved for all centers by a central Ethics Committee (IDCRB 2019-A01775-52, Comité de Protection des Personnes Bron —Région SUD-EST II, France) according to French law on October 9, 2019. This study was conducted in accordance with the ethical standards of the Declaration of Helsinki and the Good Clinical Practice requirements. Written informed consent was required for all patients prior to enrollment and randomization.
: Not applicable.
: The authors declare no competing interests.